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Introduction: Painful temporomandibular disorders (TMDs) are usually treated with physiotherapy, self-exercises,
medication-based therapy and splint therapy. For splint therapy different types of splints are available. Therefore
this randomized controlled study compared the effectiveness of a semi-finished occlusal appliance (SB) with a
laboratory-made occlusal appliance (SS) in myofascial pain patients.
Method: The trial subjects allocated to the experimental groups with the (SB) occlusal appliance and those
provided with a laboratory-made occlusal appliance (SS) did, in addition, receive conservative treatment (self-exercises,
drug-based and manual therapy). The control group was given conservative therapy (CO) only. Overall, a
total of 63 patients participated in the study with each group consisting of 21 subjects.
Results: When the first follow-up examination took place (14 days after splint insertion) mouth opening within the
SB group was significantly enlarged. When the second examination was conducted (2.5 months after splint insertion)
mouth opening was significantly enlarged in both splint groups when compared with the initial value. In the control
group, no significant enlargement of mouth opening was detected. At no point there was a significant reduction in
the number of pressure-sensitive areas of the TMJ. On palpation of the masticatory muscles however, a significant
reduction in the number of pressure-sensitive areas could be observed within the CO group and the SS group after
2.5 months.
When comparing pain reduction (muscle/joint pain) and mouth opening, no significant differences could be detected
between the treatments.
Conclusion: The results suggest that TMD should be treated conservatively. In cases of restricted mouth opening,
the additional use of occlusal appliances can eliminate the patient’s discomfort more quickly. In this context, the
tested, semi-finished occlusal appliance appears to offer an immediately available, temporary alternative to
laboratory-made splints.
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Figure 1 Semi-finished occlusal appliance prior to adjustment.
The blue occlusal liner and the handle are removed after adaptation.
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Temporomandibular disorder (TMD) represents a problem
in terms of health economics. Currently available data
suggests that, on average, 9.7% of the population suffers
from conditions covered by RDC/TMD group I diagnosis
(myofascial pain) and 11.4% from conditions covered by
RDC/TMD group IIa diagnosis (disk displacement with
reduction) [1] with the risk of women developing these dis-
orders being approximately 1.5 to 2 times higher than that
of men. 80% of patients treated for TMD are women [2-4].
Dysfunctions and functional disorders of the cranioman-
dibular system are characterized by a multitude of symp-
toms that are similar to complaints that typically affect the
human locomotor system. Examples are discoordination of
synergistic and antagonistic muscle groups, various myo-
genic types of pain (e.g. myalgia), muscular hypertrophies
and/or hypotrophies as well as arthrogenic conditions with
dysfunctional physiological joint positions and, finally,
secondary pathological changes of the temporomandibular
joints. In addition, traumatic, psychological and orthopedic
cofactors are being discussed [5].
During the search for an etiological explanation of TMD,
the initial assumption was that the cause of TMD-
associated complaints was primarily a dysfunctional occlu-
sal relationship between the upper and lower jaw and a
resulting change in the position of the lower jaw – or the
condylus in the articular fossa [6]. Meta-analyses however
were able to show that this purely biomedical approach did
not do justice to TMD [7]. Nowadays there is no doubt that
biomedical as well as psychological and psycho-social
impact factors are involved in the development of TMD
[8]. This etiological model of explanation, which has by
now been accepted, was first published as early as 1992 by
Dworkin and LeResche. Their “research diagnostic criteria
for temporomandibular disorders” (RDC/TMD) are
clearly the gold standard of TMD diagnostics in the
current scientific debate.
For a long time the assumption was that the adjusted sur-
face of the occlusal splint was essential for its effectiveness
as it led to the reconstitution of an “ideal” and/or “physio-
logical” position of the lower jaw [9,10]. Over the past few
years however, a multimodal treatment concept has come
to the fore that consists of elements such as temporary
reversible changes of occlusion with the help of occlusal
splints but also of manual therapy, biofeedback, self-
exercises and pharmacotherapy. Furthermore, psychothera-
peutic and cognitive behavioral treatment procedures are
being used [11]. With regard to splint therapy, the more re-
cent evidence confirms an effectiveness of ready-made oc-
clusal appliances or interceptors without adjusted surfaces
for the treatment of TMD-associated complaints [12,13].
The effectiveness of the mentioned occlusal appliances
is currently explained with the help of the integrated
neurobiological model [14] whose basic idea lies in theheterogeneous activation of the masticatory muscles
[15]. This is inspired by the thought that a random
change in jaw relations leads to an altered activation
pattern of the masticatory muscles that relieves previously
overstrained areas.
The semi-finished occlusal appliance called “SOLU-
BruxW”(W3 Solutions, 4ch.delaBobinette, CH-1263
Crassier, Switzerland) (Figure 1), whose effectiveness
has been tested in this study, is made of malleable
thermoplastic material on an ethyl vinyl acetate basis,
which, according to the manufacturer’s instructions, it
meant to be fitted to the upper jaw after being heated in
water. The occlusal appliance is designed in such a way
that the sections that face the buccal and oral tooth sur-
faces are thinner than those facing the occlusal surfaces.
When submerged in water, the thin sections soften to a
greater extent so that they adjust to the shape of the teeth
whilst the thicker sections change their shape only slightly.
During the fitting process, a so-called “occlusal liner” is
clipped onto the part of the occlusal appliance that faces
the lower jaw. This ensures that the splint adapts to
the compensation curves while, at the same time,
preventing an occlusal adjustment that would leave cusp
imprints (Figures 2, 3).
Trial subjects, material and method used
The trial subjects were recruited in 2009 and 2010 in the
Department of Prosthetic Dentistry and Biomaterials and
the Department of Orthodontics of the Center for Dental,
Oral and Maxillofacial Diseases of Münster University
Hospital.
The screening was performed on female and male
patients aged 18 to 80 years who had been referred there
due to TMD-associated complaints.
The patients who were deemed potentially suitable for
participation in the study were, in advance, told of the
study design during an introductory session with an
Figure 2 This shows the difference between an occlusal
appliance that has not yet been individualized (left) and one
that has been individually adjusted. The adapted occlusal
appliance has changed shape in line with the compensation curves.
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received an information leaflet. The trial subjects agreed
to take part in the study by signing a consent form.
The research project was approved by the ethics
commission of the Regional Medical Association
(Ärztekammer) of Westfalen-Lippe and the Medical Faculty
of the Westphalian Wilhelms University of Münster.
Case number estimates carried out by the Institute for
Biometrics and Clinical Research of Münster University
Hospital established that a minimum number of 15 trial
subjects was required per group.Composition of the group of trial subjects
Inclusion criteria: Included were patients who had been
diagnosed with RDC/TMD Ia or Ib (myofascial pain) also
in combination with arthralgia (IIIa) and/or disk displace-
ment with reduction (IIa) and a maximum “von Korff” pain
grade of I (functional pain with low levels of intensity) to II
(functional pain with high levels of intensity).
Exclusion criteria: Excluded were patients with other
RDC diagnoses, polyarthritides, full denture users, patients
with severe general diseases, with radiation of the maxillo-
facial area, patients who had suffered maxillo-facial trauma,
those with allergies against plastic dentistry materials, withFigure 3 Adapted, semi-finished occlusal appliance that has
been placed onto the maxillary teeth. All mandibular teeth
occlude against the planar underside of this splint.mouth openings ≤ 20 mm and those suspected of
neoplasias and mental health problems.
Patients, however, who had unsuccessfully undergone
splint therapy or other CMD treatments in the past were
not excluded.
Termination criteria: Patients suffering from an intoler-
ance to the splint material and whose mouth opening was
increasingly restricted (≤ 20 mm) stopped taking part in
the study.
The overall group of trial subjects consisted of 63
persons. They were assigned to the three different
sub-groups via randomization (21 persons per study
group) (Figure 4):Group 1
Conservative therapy: Included the use of self-exercises
(muscle exercise form according to Prof. Schulte,
self-massage techniques, mouth opening exercises),
medication-based therapy using non-steroidal anti-
inflammatory drugs (NSAID), muscle relaxants as well as
manual therapy.Group 2
Conservative therapy. In addition, a laboratory-made
stabilization splint was produced. As part of this
splint therapy, a SAMW face-bow was fitted and, in order
to establish the centric occlusion position, a bite registra-
tion was taken using Beauty PinkW wax as registration
plate and AluwaxW.Group 3
Conservative therapy. In addition, the SOLUBruxW splint
was fitted and inserted. This prefabricated, semi-finished
occlusal appliance made from malleable thermoplastic
material was produced and/or fitted in line with the
manufacturer’s instructions.
To this end, the combined occlusal liner/fork handle
was fully inserted into the appropriate opening on the
front of the SOLUBruxW splint. This was followed by an
examination of its fit in the mouth. The SOLUBruxW
splint could be reduced in size with a scalpel or a pair of
scissors. To ensure later adaptation, the patient was told
to practice pressing his tongue against the anterior palate
and, by doing so, creating a vacuum in the oral cavity.
Subsequently, the SOLUBruxW splint was heated in
boiling water for 12–15 seconds.
After taking it out, the hot water was removed from
the SOLUBruxW splint, which was then adjusted to the
mouth of the patient as described.
Patients in group 2 and 3 were told to wear the
occlusal appliance every night and two hours during
the day.
Figure 4 Diagram of study development.
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The patients were examined using a standardized protocol
(RDC/TMD). This includes establishing active and passive
incisal edge distance, the extent of excursive movements,
the deviation of jaw opening from the mid-line, palpation
of the masticatory muscles and temporomandibular
joints from lateral and dorsal as well as auscultation
of temporomandibular joint noise.
As the occlusion is not recorded in the RDC/TMD, it
was in addition documented with the help of the occlu-
sion protocol taken from functional status of the German
Society for Functional Diagnosis and Therapy (DGFDT).
This records tooth contact patterns in habitual, centric
static as well as dynamic occlusion.
Follow-up and collection of data
Findings were collected and documented at the start of
each patient’s therapy, two weeks after therapy com-
mencement as well as three months after the start of the
therapy. In case of study group 2, a further day was added
for the insertion of the laboratory-made occlusally
adjusted splint. In this group too, the second time
that findings were collected and documented was twoweeks after the insertion of the occlusally adjusted
stabilization splint.
Principles of statistic evaluation
Target parameters
The primary aim of the study was to compare the three
treatment groups with regard to pain reduction in the
palpation-sensitive masticatory muscles. The primary
outcome parameter was the difference in the number of
affected areas between the start of the study and the first
follow-up examination.
Apart from the primary evaluation, additional exploratory
evaluations were carried out. These included changes con-
cerning the reduction of pain between the commencement
of the study and the second follow-up examination as well
as changes within each treatment group. In addition,
further sections of the RDC/TMD questionnaire were eval-
uated. The resulting p-values and confidence intervals were
interpreted as descriptive measurements. Inferential statis-
tics are intended to be exploratory (hypotheses generating),
not confirmatory, and are interpreted accordingly. I.e.,
p-values are interpreted in Fisher’s sense, representing
the metric weight of evidence against the respective
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generate new hypotheses.
Statistical methods
The statistical evaluation of the primary target parameters
was performed as a confirmatory analysis that involved
the use of non-parametric statistical procedures. First,
Kruskal-Wallis tests were performed to establish any glo-
bal differences between the three treatment groups. The
global significance level was set to α = 5%. In the case of
significant test results, post-hoc analyses using two-sided
Mann–Whitney U tests were conducted. Due to multiple
comparions p-values were adjusted using Bonferroni
correction.
Differences in the extent of vertical movement, extraoral
muscle palpation and palpation of the joints within each
treatment group between the examinations were analyzed
using the Wilcoxon test with Bonferroni correction.
All statistical analyses were performed by the Institute of
Biostatstics and Clinical Research University of Münster
using the statistical software packages IBM SPSSW Statistics
20 for Windows (IBM Corporation, Somers, NY, USA) and
SAS Statistical Software (SAS v. 9.2; Statistical Analysis
System SAS Institute, Inc., Cary, NC, USA.
Results
Demographic results
The overall gender distribution was 79.4 percent in female
and 20.6 percent in male trial subjects. The median ageFigure 5 Age-dependent gender distribution.was 34.66 years. The average age of the female patients
was 33.38 years and that of the male participants was
39.60 years (Figure 5).Dropout
All trial subjects of the SB group finished the study whilst
in the CO group two participants and in the SS group three
participants dropped out (Table 1). One of the drop-outs
was due to an adenoid cystic carcinoma spreading in the
aural/temporomandibular joint area, which was detected
during the course of the study, whereby one drop-out
criterion was met. Persisting complaints and increased
swelling above the temporomandibular joint made
the investigator carry out further diagnostic imaging
procedures.Examination results
During none of the follow-up examination days statistically
significant differences could be established between the
three groups concerning the examined parameters. Gene-
rally, however, it was possible to observe a reduction in the
pressure-sensitive areas upon palpation of the muscle and
temporomandibular joint area as well as an increase in the
extent of vertical movement in all three groups.
However, when comparing these parameters within
the groups at the different follow-up examination
times, some statistically significant differences could
be established.
Table 1 Processed cases
Cases
Valid Missing
Therapy N Percent N
conservative (CO) 19 90.5% 2
occlusally adjusted (SS) 18 85.7% 3
not occlusally adjusted (SB) 21 100% 0
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movement of the lower jaw, no statistically relevant dif-
ference was found within the CO group whilst in the SS
group there was a difference between the initial findings
and the final examination after 2.5 months (P = 0.041),
and in the SB group there was a difference both between
the initial findings and the two-weekly follow-up exa-
mination (p = 0.004) and between the initial findings and
the final examination (p = 0.021) (Figure 6).
In the SB group the increase in active mouth opening
accompanied by pain between the initial findings and
the two-weekly follow-up examination was significantly
enlarged (p = 0.025).
As to the overall number of extraoral muscle palpa-
tion areas, an overall reduction in the pressure-
sensitive areas could be observed in all three groups whilstFigure 6 Extent of vertical movement. Significant differences after a Bon
brackets mark significant differences).significant changes between initial and final findings only
occurred within the CO (p = 0.002) and the SS (p = 0.027)
groups (Figure 7).
Palpation of the temporomandibular joints did not
show any statistically significant differences regarding
the reduction of pressure-sensitive areas within the three
groups. There was a conspicuously large number of
blips. However, a non-significant reduction still occurred
in all groups (Figure 8).Discussion
The gender and age distribution of the study participants
correlates with the results of epidemiological studies on
TMD. The presumption, for example, is that 80 percent of
patients who are treated for TMD are women [2,16]. John
[17] established in 2001 that the frequency of women
receiving TMD therapy is double that of men. In our study
the percentage of women was 79.4% while that of
men was 20.6%.
Clinical patient populations primarily consist of middle-
aged adults [18]. According to publications, functional
disorders typically peak when people are in their thirties or
forties with a disproportionately high number of female
sufferers. These figures are identical with the median age of
our study participants.ferroni correction of the Wilcoxon test within the groups. (p < 0.05;
Figure 7 Reduction in the number of pressure-sensitive areas upon muscle palpation. Significant differences after a Bonferroni correction
of the Wilcoxon test. (p < 0.05; brackets mark significant differences).
Figure 8 Reduction of pressure-sensitive areas during palpation of temporomandibular joints. No statistically significant differences within
the groups. (p < 0.05; brackets mark significant differences).
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between the three groups with regard to therapeutic
effectiveness.
These results concur with the studies conducted by
Truelove 2006 [12] and Alencar 2008 [19]. Truelove
compared the results of conservative therapy with those
achieved with a low-cost sport mouth guard added to
conservative therapy and those obtained with a laboratory-
made “expensive” splint that was added to conservative
treatment. As in our study, pain reduction and increased
mouth opening was observed in all three groups albeit
without significant differences. His conclusion was to treat
CMD with low-cost conservative therapy (e.g. self-exer-
cises, drug-based therapy). When comparing results he did
not see that treatment based on adjusted occlusal
appliances provided any additional benefit.
Using a double-blind controlled clinical study, Alencar
[19] compared hard, occlusally adjusted splints with soft
ones as well as with splints without antagonistic contacts
in patients with myofascial pain of the masticatory mus-
cles. Here too, all three groups noticed a reduction in
pain, which led to the conclusion that low-cost therapies
such as self-exercises are preferable to more expensive
splint-based therapies.
Our results and the above mentioned studies contradict
popular and plausibly documented models as well as our
own experience according to which occlusal splints have a
therapeutic effect on patients suffering from myogenic
CMD. Schindler and Türp 2011 [20] state that, based on
the highest levels of evidence, a specific therapeutic effect
could be confirmed in this subgroup. According to them,
particular uncomplicated complaints that are limited
to the masticatory muscles respond well to occlusal
splint treatment.
Based on a meta-analysis, Fricton concluded in 2010 that
hard, occlusally adjusted splints had a better therapeutic
effect than placebo splints or no treatment at all [21].
There are several hypotheses concerning the efficacy
of occlusion splints such as the introduction of changes
affecting behavior and awareness [22] as well as the re-
organization of functional intramuscular patterns based
on the heterogeneous activation of the masticatory
muscles, which reduces the strain on damaged muscle
sections [23,24].
Two weeks after splint insertion, an MRI scan detected
a neurocerebral effect. It found decreased activity in the
somatosensory (S1) and primary cortex (S2) as well as in
the insular cortex (higher-level pain perception) and an
activation of parietal brain sections that are used for the
control of precise coordinated movements [25].
Splints have also proven to be therapeutically effective
in cases of disk displacement [26-28]. Compared with
untreated control groups, the treatment success of splint
therapy was noticeable much earlier.In view of the above, the question necessarily remains as
to why the occlusal splints used in this study did not result
in the desired additional therapeutic effect concerning
muscle and temporomandibular joint pain.
What would need to be discussed is the choice of a
dental hospital with TMD consultation hours as the
place of treatment. We must ask ourselves whether the
patients who were examined there are a representative
section of all patients with TMD symptoms or whether,
from the very beginning, the patient selection led to an
unavoidable bias effect.
Concerning their prognosis, patients referred by their
dentists to a dental hospital or who decide to go there of
their own accord (e.g. because they are not satisfied with
the current treatment provided by their dentist) could
be different from patients who never consulted a doctor
regarding their complaints or whose treatment their
dentist was confident enough to provide.
It is a well-known fact that patients who are referred
to specialist pain clinics complain about more persistent
pain and greater functional restrictions are more likely
to have been through unsuccessful prior treatments and
generally benefit least from any intervention [29]. The
results of this study may therefore only be transferred to
similar patient groups.
Within the SB and SS groups, significantly increased
mouth opening could be observed with this effect occur-
ring even earlier in patients fitted with a SOLUBruxW
occlusal appliance.
There could be various explanations for this effect. When
splints are fitted, the mouth needs to open wider, which
could lead to a stretching effect. This could also explain
why the effect is faster when a SOLUBruxW occlusal appli-
ance was used, because it is significantly thicker than a nor-
mal stabilization splint. In addition, the splints could have
resulted in a relaxation of the tense and shortened mastica-
tory muscles, which led to a normalization of muscle tone
and an enlarged mouth opening. Even certain distractive
effects of the splints due to an increase in the vertical di-
mension are possible, which could have reduced the strain
on the temporomandibular joint structures. Furthermore,
the immediate availability of the splint could have had a
positive effect on mouth opening because other tests have
shown that an early use of splint therapy causes a greater
increase in mouth opening [30].
Conclusion
This randomized controlled study did not establish signifi-
cant differences regarding pain reduction (muscular/joint
pain) and mouth opening between the various therapeutic
approaches.
These results suggest that TMD should initially be trea-
ted with conservative therapy consisting of self-exercises
as well as drug-based and manual treatment.
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of mouth opening was observed within the SB and SS
groups, which was missing within the CO group. This
effect occurred more rapidly with the semi-finished
SOLU-BruxW occlusal appliance than with the laboratory-
finished occlusion splints. Hence, the use of occlusal appli-
ances, particular in cases of restricted mouth opening,
continues to make sense as it alleviates complaints
more quickly. The immediate availability of semi-
finished occlusal appliances, which can directly be adapted
to the individual patient, may be an advantage.
The question is how far results that have been obtained
in a specialist facility can be transferred to a general
dentist’s practice considering that bias effects must be
expected that originate from the patient population itself.
This requires further research in order to establish to what
extent such differences actually exist.
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